These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 18157387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH.
    Correa-Silva SR, Nascif SO, Molica P, Sá LB, Vieira JG, Lengyel AM.
    Eur J Endocrinol; 2009 Nov; 161(5):681-6. PubMed ID: 19696160
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR, Nascif SO, Lengyel AM.
    Pituitary; 2006 Nov; 9(2):101-7. PubMed ID: 16832586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
    de Sá LB, Nascif SO, Correa-Silva SR, Molica P, Vieira JG, Dib SA, Lengyel AM.
    Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
    [Abstract] [Full Text] [Related]

  • 7. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.
    Molica P, Nascif SO, Correa-Silva SR, de Sá LB, Vieira JG, Lengyel AM.
    Pituitary; 2010 Dec; 13(4):315-23. PubMed ID: 20602173
    [Abstract] [Full Text] [Related]

  • 8. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [Abstract] [Full Text] [Related]

  • 9. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
    Oliveira JH, Vieira JG, Abucham J, Lengyel AM.
    J Endocrinol Invest; 2003 Mar; 26(3):230-5. PubMed ID: 12809173
    [Abstract] [Full Text] [Related]

  • 10. Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6.
    Micic D, Macut D, Sumarac-Dumanovic M, Kendereski A, Popovic V, Deghenghi R, Dieguez C, Casanueva FF.
    Eur J Endocrinol; 2002 Dec; 147(6):761-6. PubMed ID: 12457451
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [Abstract] [Full Text] [Related]

  • 12. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
    Bhatti SF, De Vliegher SP, Van Ham L, Kooistra HS.
    Mol Cell Endocrinol; 2002 Nov 29; 197(1-2):97-103. PubMed ID: 12431802
    [Abstract] [Full Text] [Related]

  • 13. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E, di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E.
    Peptides; 1997 Nov 29; 18(6):885-91. PubMed ID: 9285939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 29; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administration.
    Frieboes RM, Murck H, Antonijevic IA, Steiger A.
    J Neuroendocrinol; 1999 Jun 29; 11(6):473-8. PubMed ID: 10336729
    [Abstract] [Full Text] [Related]

  • 19. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE, Bonomo SM, Cella SG, Müller EE.
    J Endocrinol; 2002 Sep 29; 174(3):387-94. PubMed ID: 12208658
    [Abstract] [Full Text] [Related]

  • 20. Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
    Miljić D, Polovina S, Doknić M, Pekić S, Stojanović M, Petakov M, Micić D, Popović V.
    Neuroendocrinology; 2017 Sep 29; 104(1):33-39. PubMed ID: 26836811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.